SS
Highly rated in
10
conditions
Highly rated in
10
conditions
Check Dr. Shalini M. Shenoy's experience treating your condition:
About Dr. Shalini M. Shenoy

Shalini Shenoy is a Hematologist Oncology specialist and a Pediatrics expert in Twn And Cntry, Missouri. Shenoy has been practicing medicine for over 41 years and is highly rated in 10 conditions, according to our data. Her top areas of expertise are Hemoglobinopathy, Hemolytic Anemia, Congenital Hemolytic Anemia, and Sickle Cell Disease. She is licensed to treat patients in Missouri. Shenoy is currently accepting new patients.

Her clinical research consists of co-authoring 130 peer reviewed articles and participating in 11 clinical trials in the past 15 years.

Locations
13001 N Outer 40 Rd, Childrens Specialty Care Center, Twn And Cntry, MO 63017
Other Locations
13001 N Outer 40 Rd, Childrens Specialty Care Center, Twn And Cntry, MO 63017
1020 North Mason Road, Suite: 110, Creve Coeur, MO 63141
1 Childrens Pl, St Louis, MO 63110
Background & Education
Graduate Institution
Other, 1981.0
Specialties
Hematology Oncology
Pediatrics
Pediatric Hematology Oncology
Licenses
Pediatrics in MO
Hospital Affiliations
St Louis Childrens Hospital
Barnes-Jewish Hospital
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


11 Clinical Trials

Anti-Angiogenic Therapy After Autologous Stem Cell Rescue (ASCR) for Pediatric Solid Tumors
A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations
A Phase I/II Trial of Reduced Intensity Conditioning and Familial HLA-Mismatched Bone Marrow Transplantation in Children With Non-Malignant Disorders
Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant in Children and Adults
Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for the Treatment of Bone Marrow Failure Diseases
A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease Using a Reduced-Intensity Preparatory Regime
A Pilot Trial of Unrelated Donor Hematopoietic Cell Transplantation for Children With Severe Thalassemia Using a Reduced Intensity Conditioning Regimen (The URTH Trial)
A Phase 2 Study of Cytokine-induced Memory-like NK Cells in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed AML
View 3 Less Clinical Trials -

129 Total Publications

Umbilical cord blood as a hematopoietic stem cell source in transplantation for pediatric sickle cell disease: Current challenges and strategies.
Summary: Umbilical cord blood as a hematopoietic stem cell source in transplantation for pediatric sickle cell disease: Current challenges and strategies.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors